CTA018 Completed Phase 2 Trials for Psoriasis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00384098Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis